Panong, Rolando .

HRN: 26-72-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/15/2025
09/22/2025
IV
2.25g
Q6h
Perforated Peptic Ulcer
Waiting Final Action 
09/15/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/15/2025
09/15/2025
IV
4.5g
Once
Perforated Peptic Ulcer
Waiting Final Action 
09/15/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/15/2025
09/29/2025
IV
500mg
Q8h
Perforated Peptic Ulcer
Checking Initial Appropriateness 
09/17/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/15/2025
09/22/2025
IV
2.25g
Q6hr
Perforated Peptic Ulcer
Waiting Final Action 
09/18/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/18/2025
10/01/2025
IV
4.5
Q8h
Perforated Viscus
Waiting Final Action 
09/27/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/27/2025
10/04/2025
IV
750
OD
Sepsis
Checking Initial Appropriateness 
09/28/2025
MUPIROCIN 2%, 15G (TUBE)
09/28/2025
10/05/2025
TOPICAL
1
Bid
SP Exlap
Checking Final Appropriateness 
09/28/2025
CLARITHROMYCIN 500MG (CAP)
09/28/2025
10/12/2025
ORAL
500mg
Q12
H Pylori
Checking Final Appropriateness 
09/28/2025
AMOXICILLIN 500MG CAPSULE (CAP)
09/28/2025
10/12/2025
ORAL
500mg
Q12
H Pylori
Checking Final Appropriateness 
10/04/2025
CEFIXIME 200MG (CAP)
10/04/2025
10/10/2025
PO
200mg
BID
Sepsis
Waiting Final Action 
10/04/2025
CLINDAMYCIN 300MG (CAP)
10/04/2025
10/10/2025
PO
300mg
TID
Infected Diaper Rash; Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: